Pharmiweb ChannelsAll | PharmaCo | Clinical Research | R&D/BioTech | Sales/Mktg | Healthcare | Recruitment | Pharmacy | Medical Comms

Pharmiweb.com RSS Feed Pharmiweb.com RSS Feeds

Pharmiweb.com RSS Feed PharmiWeb Candidate Blog

Pharmiweb.com RSS Feed PharmiWeb Client Blog

Advertising

Press Releases

593 Press Releases
DateTitleCompany
09 Oct 13 ChapStick® Announces Olympic Gold Medalist Alex Morgan As New Face of the Brand Pfizer Inc.,
Published by
Business Wire
08 Oct 13 Scottish patients first in the UK to benefit from a positive health technology assessment for lung cancer medicine Xalkori® (crizotinib) Pfizer Oncology
03 Oct 13 International Atherosclerosis Society And Pfizer Independent Grants For Learning & Change Collaborate On New Grant Opportunity Pfizer,
Published by
Business Wire
01 Oct 13 Pfizer Invites Public To View And Listen To Webcast Of October 29 Conference Call With Analysts Pfizer Inc.,
Published by
Business Wire
30 Sep 13 Shantanu Narayen Elected To Pfizer's Board Of Directors Pfizer Inc.,
Published by
Business Wire
30 Sep 13 Advil® Becomes Official Pain Reliever of the National Hockey League and the 30 Team Athletic Trainers Pfizer Inc.,
Published by
Business Wire
19 Sep 13 CHAMPIX® (varenicline) IS EFFECTIVE AND WELL TOLERATED COMPARED WITH PLACEBO IN PATIENTS WITH A HISTORY OF MAJOR DEPRESSIVE DISORDER (MDD) Pfizer UK Ltd,
Published by
Just:: Health Communications
26 Aug 13 Introducing New Advil® Film Coated Tablets – Designed to Stop Pain Before It Gets Worse Pfizer Inc.,
Published by
Business Wire
29 Jul 13 Pfizer To Create Separate, Internal, Global Innovative And Value Businesses Pfizer,
Published by
Business Wire
10 Jul 13 New survey on Atlanta Attitudes Toward Aging To Be Released Thursday, July 11 Pfizer,
Published by
Business Wire
28 Jun 13 Pfizer Declares 24-Cent Third-Quarter 2013 Dividend Pfizer Inc.,
Published by
Business Wire
27 Jun 13 Pfizer Announces Final Results of Zoetis Exchange Offer Pfizer Inc.,
Published by
Business Wire
25 Jun 13 Pfizer Invites Public To View And Listen To Webcast Of July 30 Conference Call With Analysts Pfizer Inc.,
Published by
Business Wire
20 Jun 13 US News and World Report and Pharmacy Times Survey: Advil®, Centrum® and Robitussin® are #1 Pharmacist Recommended Pfizer,
Published by
Business Wire
12 Jun 13 Pfizer Obtains $2.15 Billion Settlement from Teva and Sun for Infringement of Protonix® Patent Pfizer Inc.,
Published by
Business Wire
05 Jun 13 Boxing Champ Laila Ali Kicks-off Pfizer “Get Old” Wellness Campaign at Interactive Times Square Event -- Wednesday, June 5 at Noon EDT PFIZER,
Published by
Business Wire
29 May 13 Pfizer Prices $4.0 Billion Debt Offering Pfizer Inc.,
Published by
Business Wire
25 Apr 13 Top-Line Data Show Celecoxib Met Primary Objective In Clinical Trial To Evaluate The Effects On Blood Pressure In Pediatric Patients With Juvenile Idiopathic Arthritis Pfizer Inc.,
Published by
Business Wire
19 Apr 13 Pfizer Invites Public To Listen To Webcast Of April 25 Annual Meeting Of Shareholders Pfizer Inc.,
Published by
Business Wire
26 Mar 13 Pfizer Invites Public to View and Listen to Webcast of April 30 Conference Call with Analysts Pfizer Inc.,
Published by
Business Wire
25 Mar 13 XELJANZ® (tofacitinib citrate) Approved in Japan for the Treatment of Adults with Rheumatoid Arthritis (RA) Pfizer Inc.,
Published by
Business Wire
05 Mar 13 United States Patent & Trademark Office Grants Pfizer Reissue Patent For Celebrex® (celecoxib capsules) Pfizer Inc.,
Published by
Business Wire
21 Feb 13 Top-Line Data Show Lyrica Met Primary Endpoint in Clinical Trial as Adjunctive Therapy versus Levetiracetam in Patients with Partial Onset Seizures Pfizer Inc.,
Published by
Business Wire
01 Feb 13 Pfizer Inc. Issues Statement on ZoetisTM IPO Pfizer Inc.,
Published by
Business Wire
31 Jan 13 Pfizer Wins RAPAMUNE® Patent Case in Delaware District Court Pfizer Inc.,
Published by
Business Wire
29 Jan 13 Pfizer Reports Fourth-Quarter and Full-Year 2012 Results; Provides 2013 Financial Guidance Pfizer Inc.,
Published by
Business Wire
26 Jan 13 Pfizer Receives FDA Approval For The Use Of Prevnar 13 In Vaccine-Naive Children And Adolescents Aged 6 Years Through 17 Years For The Prevention Of Invasive Pneumococcal Disease Pfizer Inc.,
Published by
Business Wire
24 Jan 13 ChapStick® Sessions Applies a Spotlight on Musically Talented Lips Pfizer,
Published by
Business Wire
24 Jan 13 Study Shows Higher Dose Of Toviaz® (fesoterodine fumarate) Offers Greater Efficacy In Reducing Urge Urinary Incontinence In Patients With Overactive Bladder Pfizer Inc.,
Published by
Business Wire
24 Jan 13 Pfizer Announces Top-Line Efficacy Results From A Phase 4 Study Of PRISTIQ® (desvenlafaxine) For The Treatment Of Major Depressive Disorder (MDD) In Adults Pfizer Inc.,
Published by
Business Wire
Advertising
Share | | |
Site Map | Privacy & Security | Cookies | Terms and Conditions

PharmiWeb.com is Europe's leading industry-sponsored portal for the Pharmaceutical sector, providing the latest jobs, news, features and events listings.
The information provided on PharmiWeb.com is designed to support, not replace, the relationship that exists between a patient/site visitor and his/her physician.